RhumbLine Advisers’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Sell |
1,029,698
-27,501
| -3% | -$310K | 0.01% | 994 |
|
|
2025
Q1 | $10.7M | Sell |
1,057,199
-17,892
| -2% | -$181K | 0.01% | 990 |
|
|
2024
Q4 | $12.7M | Sell |
1,075,091
-11,498
| -1% | -$136K | 0.01% | 939 |
|
|
2024
Q3 | $12.5M | Buy |
1,086,589
+200,096
| +23% | +$2.31M | 0.01% | 958 |
|
|
2024
Q2 | $9.37M | Sell |
886,493
-70,856
| -7% | -$749K | 0.01% | 1057 |
|
|
2024
Q1 | $10.1M | Buy |
957,349
+535,708
| +127% | +$5.65M | 0.01% | 1040 |
|
|
2023
Q4 | $4.73M | Buy |
421,641
+14,290
| +4% | +$160K | 0.01% | 1453 |
|
|
2023
Q3 | $4.76M | Buy |
407,351
+107,251
| +36% | +$1.25M | 0.01% | 1377 |
|
|
2023
Q2 | $3.03M | Buy |
+300,100
| New | +$3.03M | ﹤0.01% | 1679 |
|